These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10416484)

  • 41. Setting up a randomized clinical trial in the UK: approvals and process.
    Greene LE; Bearn DR
    J Orthod; 2013 Jun; 40(2):104-11. PubMed ID: 23794690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.
    Freeman TB; Vawter DE; Leaverton PE; Godbold JH; Hauser RA; Goetz CG; Olanow CW
    N Engl J Med; 1999 Sep; 341(13):988-92. PubMed ID: 10498497
    [No Abstract]   [Full Text] [Related]  

  • 43. Sequential assignment and treatment-as-usual. Alternatives to standard experimental designs in field studies of treatment efficacy.
    Staines GL; McKendrick K; Perlis T; Sacks S; De Leon G
    Eval Rev; 1999 Feb; 23(1):47-76. PubMed ID: 10346073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression.
    Pigott HE
    Can J Psychiatry; 2015 Jan; 60(1):9-13. PubMed ID: 25886544
    [No Abstract]   [Full Text] [Related]  

  • 45. Mega-trials: methodological issues and clinical implications.
    Charlton BG
    J R Coll Physicians Lond; 1995; 29(2):96-100. PubMed ID: 7595900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding research: 1. Methodologies used to answer research questions.
    Baxter H
    J Wound Care; 2001 Jul; 10(7):269-72. PubMed ID: 12964346
    [No Abstract]   [Full Text] [Related]  

  • 47. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
    Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The institutional review board and beyond: future challenges to the ethics of human experimentation.
    Edgar H; Rothman DJ
    Milbank Q; 1995; 73(4):489-506. PubMed ID: 7491097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A lesson from Melos.
    Owen JA
    Hosp Formul; 1979 Feb; 14(2):127. PubMed ID: 10240142
    [No Abstract]   [Full Text] [Related]  

  • 51. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The Bavarian Ethics Committee. Current status in overview].
    Piechowiak H
    Fortschr Med; 1983 Aug; 101(29):1344-7. PubMed ID: 6618392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Medical ethics committees, role and function in scientific research].
    Boer EJ
    Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1659-64. PubMed ID: 2797277
    [No Abstract]   [Full Text] [Related]  

  • 54. Fumes from the spleen.
    Paediatr Perinat Epidemiol; 1996 Jul; 10(3):264-7. PubMed ID: 8822769
    [No Abstract]   [Full Text] [Related]  

  • 55. The ISAT trial.
    Britz GW; Newell DW; West GA; Lam A
    Lancet; 2003 Feb; 361(9355):431-2; author reply 432. PubMed ID: 12573405
    [No Abstract]   [Full Text] [Related]  

  • 56. [Ethics committees: international experience and of the National Institute for cancer research of Genoa].
    Sinaccio G; Robert E; Corda A; Dagnino G; Rosmino E; Gipponi M
    Minerva Med; 1990 Dec; 81(12):869-73. PubMed ID: 2280878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethical issues with the disclosure of surgical trial short-term data.
    Allardyce RA; Bagshaw PF; Frampton CM; Frizelle FA; Hewett PJ; Rieger NA; Smith JS; Solomon MJ; Stevenson AR
    ANZ J Surg; 2011 Mar; 81(3):125-31. PubMed ID: 21342382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Members of research ethics committees accepted a modification of the randomized consent design.
    Schellings R; Kessels AG; Ter Riet G; Kleijnen J; Leffers P; Knottnerus JA; Sturmans F
    J Clin Epidemiol; 2005 Jun; 58(6):589-94. PubMed ID: 15878472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Roaming through the methodology. XX. Randomization as a means of avoiding confounding through indication].
    Zielhuis GA
    Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1528-31. PubMed ID: 10949635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.
    Korn EL; Freidlin B; Mooney M
    J Clin Oncol; 2009 Apr; 27(10):1712-21. PubMed ID: 19237631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.